Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 19 November 2024
First Online: 25 November 2024
Declarations
:
: Dr. Hanna has served on advisory boards for Alnylam Pharmaceuticals, Eidos, Ionis, Alexion Pharmaceuticals, and Pfizer. Dr. Martyn serves as an advisor or receives consulting fees from Cleveland Clinic/American Well Joint Venture, Boehringer Ingelheim/Eli Lilly, Novo Nordisk, AstraZeneca, Fire1, Prolaio, Pfizer, BridgeBio, has equity in Apricity Robotics and Kilele Health, and receives grant support from Ionis Therapeutics/AstraZeneca and the Heart Failure Society of America (HFSA). All other authors have no relationships to disclose.
